December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Nucleocytoplasmic Distribution Of Opioid Growth Factor (OGF) And OGF Receptor In Rat Cornea
Author Affiliations & Notes
  • IS Zagon
    Neuroscience and Anatomy
    Penn State University College of Medicine Hershey PA
  • JW Sassani
    Ophthalmology
    Penn State University College of Medicine Hershey PA
  • TB Ruth
    Neuroscience and Anatomy
    Penn State University College of Medicine Hershey PA
  • AE Leure-duPree
    Neuroscience and Anatomy
    Penn State University College of Medicine Hershey PA
  • PJ McLaughlin
    Neuroscience and Anatomy
    Penn State University College of Medicine Hershey PA
  • Footnotes
    Commercial Relationships   I.S. Zagon, None; J.W. Sassani, None; T.B. Ruth, None; A.E. Leure-duPree, None; P.J. McLaughlin, None. Grant Identification: NIH Grants EY10300, EY13086, and EY13734
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1654. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      IS Zagon, JW Sassani, TB Ruth, AE Leure-duPree, PJ McLaughlin; Nucleocytoplasmic Distribution Of Opioid Growth Factor (OGF) And OGF Receptor In Rat Cornea . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1654.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : The native opioid growth factor (OGF), [Met5]-enkephalin, is a tonic inhibitory peptide that modulates cell proliferation and migration, as well as tissue organization, during development, homeostatic cellular renewal, and wound healing. OGF action is mediated by the OGF receptor (OGFr). Purpose: To determine the subcellular location(s) of OGFr and OGF in rat corneal epithelium. Method: Immunoelectron microscopic studies were performed using a postembedding procedure and immunogold labeling of epithelium from peripheral rat cornea. Following fixation and embedding in Unicryl, sections were stained with antibodies to OGFr and/or OGF; secondary antibodies were conjugated to 6 or 10 nm gold particles. Both single and double-face labeling studies were performed. Results: Immunogold labeling of OGFr was detected proximal to the outer nuclear envelope, in putative nuclear pores, within the inner nuclear matrix, in a paranuclear position, and at the periphery of heterochromatin. OGF was found in locations similar to OGFr, as well as in aggregates extending from the plasma membrane to the nuclear envelope. OGFr and OGF were localized in both the basal and suprabasal layers. Double labeling experiments revealed OGFr-OGF complexes that were colocalized on the outer nuclear envelope, in the paranuclear cytoplasm, extending across the nuclear envelope, and in the nucleus. Conclusion: These results are consistent with previous pharmacological, biochemical, and structural studies indicating a nuclear association of OGFr, and show that the receptor is located on the outer nuclear envelope. It appears that OGF is an autocrine produced peptide that is secreted into the extracellular milieu, and imported to the outer nuclear envelope where it interacts with the OGF receptor. The OGF-OGFr complex translocates across the nuclear pore where OGF-OGFr becomes associated at the heterochromatin-euchromatin margin, and thereby presumably participates in the governing of DNA synthesis.

Keywords: 423 growth factors/growth factor receptors • 472 microscopy: electron microscopy • 541 receptors: pharmacology/physiology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×